Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N00-N99- Diseases of the genitourinary system
Conditions
Interventions
Intervention1: Dexamethasone: group-1 patient -receive dexamethasone with normal saline upto 4ml
group 2-patient-receive normal saline 4ml
frequency-only 1time in 1 patient
route of administration-in
Sponsors
kunal prasad gupta
Eligibility
Inclusion criteria
Inclusion criteria: 1-patients posted for elective laparoscopic hysterectomy under general anaesthesia 2-ASA physical status 1 and 2 3-non-diabetic
Exclusion criteria
Exclusion criteria: 1-patient refusal 2-history of allergy to the study drug 3-pregnancy 4-renal/hepatic disease 5-immunocompromised patients 6-patients on steroids therapy 7-duration of anaesthesia more than 4hours 8-history of peptic ulcer disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose level in fasting and postprandialTimepoint: Blood glucose estimations (FBS)in 2hour 4hourand 6hour after giving single dose of dexamethasone again FBS and PPBS blood sugar estimations in POD1,POD2 AND POD3 | — |
Secondary
| Measure | Time frame |
|---|---|
| post operative nausea & vomiting upto POD1 post operative analgesics drug requirement upto POD1 observation of wound healing upto POD3Timepoint: blood glucose level upto 72 hours | — |
Countries
India
Contacts
Public ContactDr Mousumi Das
Kalinga Institute Of Medical Sciences
Outcome results
None listed